Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2014 2
2015 1
2017 2
2018 1
2019 1
2020 3
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality.
Shi T, Burg AR, Caldwell JT, Roskin KM, Castro-Rojas CM, Chukwuma PC, Gray GI, Foote SG, Alonso JA, Cuda CM, Allman DA, Rush JS, Regnier CH, Wieczorek G, Alloway RR, Shields AR, Baker BM, Woodle ES, Hildeman DA. Shi T, et al. Among authors: shields ar. J Clin Invest. 2023 Jul 17;133(14):e170191. doi: 10.1172/JCI170191. J Clin Invest. 2023. PMID: 37227784 Free PMC article.
Proteasome inhibition for antibody-mediated allograft rejection.
Sadaka B, Alloway RR, Shields AR, Schmidt NM, Woodle ES. Sadaka B, et al. Among authors: shields ar. Semin Hematol. 2012 Jul;49(3):263-9. doi: 10.1053/j.seminhematol.2012.04.008. Semin Hematol. 2012. PMID: 22726550 Review.
Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonality.
Shi T, Burg AR, Caldwell JT, Roskin K, Castro-Rojas CM, Chukwuma PC, Gray GI, Foote SG, Alonso J, Cuda CM, Allman DA, Rush JS, Regnier CH, Wieczorek G, Alloway RR, Shields AR, Baker BM, Woodle ES, Hildeman DA. Shi T, et al. Among authors: shields ar. bioRxiv [Preprint]. 2023 Feb 13:2023.02.08.524808. doi: 10.1101/2023.02.08.524808. bioRxiv. 2023. PMID: 36798151 Free PMC article. Updated. Preprint.
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.
Kaufman DB, Woodle ES, Shields AR, Leone J, Matas A, Wiseman A, West-Thielke P, Sa T, King EC, Alloway RR; BEST Study Group. Kaufman DB, et al. Among authors: shields ar. Clin J Am Soc Nephrol. 2021 Sep;16(9):1387-1397. doi: 10.2215/CJN.13100820. Epub 2021 Jul 7. Clin J Am Soc Nephrol. 2021. PMID: 34233921 Free PMC article. Clinical Trial.
Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial.
Woodle ES, Kaufman DB, Shields AR, Leone J, Matas A, Wiseman A, West-Thielke P, Sa T, King EC, Alloway RR; BEST Study Group. Woodle ES, et al. Among authors: shields ar. Am J Transplant. 2020 Apr;20(4):1039-1055. doi: 10.1111/ajt.15688. Epub 2020 Feb 6. Am J Transplant. 2020. PMID: 31680394 Free article. Clinical Trial.
15 results